The global pharmaceutical gelatin market size is expected to reach USD 2.17 billion by 2032, is expected to grow at a CAGR of 6% during the forecast period.
Pharmaceutical gelatin, derived from animal collagen, is widely used in the pharmaceutical and healthcare industries due to its unique functional properties. It serves as a critical ingredient in the manufacturing of capsules, tablets, soft gels, plasma expanders, and wound care products. The market has seen robust growth owing to the increasing demand for innovative drug delivery systems, biocompatible materials, and advancements in healthcare technology. The global pharmaceutical gelatin market is characterized by its high degree of regulation and stringent quality standards, ensuring that products meet the safety and efficacy requirements for medical applications.
𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
Competitive Insight
Some of the major players operating in the global market include
- Tessenderlo Group,
- Rousselot,
- Nitta Gelatin Inc.,
- Gelita AG,
- Catelent Inc.,
- Capsugel,
- Norland Products Inc,
- Roxlor llc,
- Weishardt, and
- Trobas Pharmaceutical Gelatine B.V,
- Sterling Gelatin,
- Aspire Pharmaceuticals,
- Junca Gelatines,
- Gelco International,
- Lapi Gelatine S.p.a.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
Pharmaceutical Gelatin Market, Source Outlook (Revenue – USD Billion, 2019-2032)
- Porcine
- Bovine Skin
- Bovine Bone
- Fish
- Poultry
Pharmaceutical Gelatin Market, Function Outlook (Revenue – USD Billion, 2019-2032)
- Stabilizing
- Thickening
- Gelling
Pharmaceutical Gelatin Market, End-Use Outlook (Revenue – USD Billion, 2019-2032)
- Hard Capsule
- Soft Capsule
- Tablet
- Absorbable Hemostat
Market Growth Drivers
- Rising Demand for Capsule-Based Drug Delivery Systems The growing preference for capsule-based formulations, driven by their ease of consumption, faster dissolution rates, and ability to mask unpleasant tastes, has significantly propelled the demand for pharmaceutical gelatin. Softgel capsules, in particular, have gained popularity for their ability to encapsulate liquid and semi-solid formulations.
- Increasing Geriatric Population With the global aging population on the rise, there is a growing need for pharmaceuticals that are easy to consume and digest. Gelatin-based capsules and supplements are particularly suited for elderly individuals, boosting market demand.
- Growth of Biopharmaceuticals and Nutraceuticals The expanding biopharmaceutical and nutraceutical industries have created a surge in demand for high-purity, pharmaceutical-grade gelatin. These industries require gelatin for specialized applications, including controlled-release drug delivery and enhanced bioavailability.
- Advancements in Wound Care and Hemostatic Products Pharmaceutical gelatin’s role in wound care products, such as sponges and dressings, and its use in hemostatic agents for controlling bleeding during surgeries are other key drivers of market growth.
Key Trends
- Shift Towards Bovine and Porcine Gelatin While both bovine and porcine sources dominate the market, the trend toward bovine gelatin is growing due to fewer cultural and religious restrictions. Additionally, manufacturers are exploring fish-derived gelatin as a potential alternative to cater to vegan and vegetarian preferences.
- Adoption of Halal and Kosher-Certified Gelatin To meet the dietary and religious requirements of diverse consumer bases, companies are increasingly offering halal- and kosher-certified gelatin products.
- Sustainability and Ethical Sourcing With increasing awareness of sustainability and animal welfare, manufacturers are adopting ethical sourcing practices and exploring alternative collagen sources to reduce their environmental impact.
- Technological Advancements in Gelatin Processing Innovations in gelatin extraction and processing technologies are enhancing product quality, improving yield, and reducing production costs. This trend is enabling manufacturers to cater to the growing demand for high-quality pharmaceutical gelatin.
Research Scope
The pharmaceutical gelatin market offers extensive opportunities for research and development. Key areas of focus include:
- Development of Plant-Based Alternatives: With the growing vegan and vegetarian population, there is a significant scope for developing plant-based gelatin substitutes that offer comparable functional properties.
- Improved Drug Delivery Systems: Research on enhancing the bioavailability, stability, and controlled release of drugs using gelatin-based systems.
- Biodegradable and Sustainable Solutions: Exploration of biodegradable gelatin materials for wound care and medical implants to align with global sustainability goals.
- Customization for Specific Applications: Innovations in customizing gelatin formulations for specific therapeutic applications, such as oncology, neurology, and cardiovascular treatments.
Future Scope
The future of the pharmaceutical gelatin market looks promising, with several growth avenues anticipated:
- Expansion in Emerging Markets Rapid urbanization, improving healthcare infrastructure, and increasing disposable incomes in emerging economies such as India, China, and Brazil are expected to drive market expansion.
- Collaboration with Biopharmaceutical Companies Strategic collaborations between gelatin manufacturers and biopharmaceutical companies will foster the development of innovative drug delivery solutions, further expanding the market.
- Focus on Personalized Medicine The growing emphasis on personalized medicine will boost the demand for gelatin-based capsules and drug delivery systems tailored to individual patient needs.
- Growth in Regenerative Medicine Gelatin’s role in tissue engineering and regenerative medicine is set to expand, opening new possibilities in advanced medical treatments and therapies.
Recent Developments
- In 2022, Lonza addressed the food industry’s need to meet European Union standards by expanding its Capsugel portfolio with a titanium dioxide-free (TiO2-free) white hard gelatin capsule.
- In May 2021, Darling Ingredients Inc., under its Rousselot brand, introduced X-Pure GelDAT (Gelatin Desaminotyrosine) for biomedical applications, further expanding its line of purified pharmaceutical-grade modified gelatins.
- In July 2022, Gelita launched a biotech hub focused on producing proteins through biotechnological methods for use in pharmaceuticals, medical products, cosmetics, and nutrition.
The market is therefore predicted to grow throughout the forecast period due to the innovations offered by gelatin and the rise in demand for pharmaceutical gelatin. However, factors such as the growing veganism trend, societal constraints, and human negative effects from using animal-derived gelatin, among others, are anticipated to restrain market expansion